22157.jpg
Insights on the Pharma Ophthalmic Global Market to 2026 - Featuring Roche, Santen and Senju Among Others
16 déc. 2021 09h48 HE | Research and Markets
Dublin, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The "Pharma Ophthalmic Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type" report...
IMED+NTC website 790x590 30 Nov 2021
NTC and I-MED Pharma form strategic partnership to bring the leading HA-based dry eye ointment to the United States market
15 déc. 2021 07h00 HE | I-MED Pharma
MONTREAL, Dec. 15, 2021 (GLOBE NEWSWIRE) -- NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and...
Michelle Schnabel picture
I-MED Pharma USA Announces Michelle Schnabel as VP Business Development
09 nov. 2021 11h00 HE | I-MED Pharma
MONTREAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Michelle Schnabel to the role of VP Business...
image0
I-MED Pharma USA Announces Brent Jones as Chief Commercial Officer
08 nov. 2021 11h00 HE | I-MED Pharma
MONTREAL, Nov. 08, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Brent Jones to Chief Commercial Officer...
I-MEDPharma_Logo_2017 pressrelease (002).jpg
I-MED Pharma Set to Launch Its Innovative Dry Eye Product Portfolio in the U.S.A.
05 nov. 2021 11h00 HE | I-MED Pharma
MONTREAL, Nov. 05, 2021 (GLOBE NEWSWIRE) -- I-MED Pharma USA is bringing the world’s most innovative dry eye product portfolio to the U.S. market. Their uniquely formulated line of ocular surface...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotechnologies Appoints Clinical Research and DED Expert Dr. Michael E. Stern to its Medical Advisory Board
02 nov. 2021 09h00 HE | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
22157.jpg
United Market Study of Dry Eye Sufferers 2021: Focus on Self-diagnosed and Physician-diagnosed Dry Eye, Detailing Symptoms, Severity and Treatment, Among Other Topics
02 nov. 2021 04h53 HE | Research and Markets
Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The "The 2021 Study of the U.S Market of Dry Eye Sufferers " report has been added to ResearchAndMarkets.com's offering. The 2021 Study of Dry Eye...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotechnologies Appoints Dry Eye Disease Expert and Accomplished Optometrist Dr. Kelly K. Nichols to its Medical Advisory Board
20 oct. 2021 09h00 HE | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
Scott McNealy
Silicon Valley Veteran Scott McNealy Joins EyecareLive's Advisory Board
12 oct. 2021 09h00 HE | EyecareLive
SANTA CLARA, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- EyecareLive, a digital eye care platform and a telehealth services provider today announced that Silicon Valley veteran Scott McNealy has...
Axim-Sapphire_Logo_-04 (1).png
AXIM® Biotechnologies Appoints Leading US Ophthalmic Surgeon and Researcher Dr. Henry D. Perry to its Medical Advisory Board
11 oct. 2021 09h00 HE | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...